Cargando…
Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review
BACKGROUND: Paliperidone (9-hydroxyrisperidone), the major active metabolite of risperidone, has been introduced as a novel atypical antipsychotic agent in many countries. It is available both as an oral extended-release (ER) formulation and as a long-acting injection (paliperidone palmitate, PP), w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714741/ https://www.ncbi.nlm.nih.gov/pubmed/26811684 http://dx.doi.org/10.2147/NDT.S64672 |